HIGHLIGHTS
- who: Piet van der Keylen and collaborators from the persons in Germany Institute of General Practice, Friedrich-Alexander-University Erlangen-Nuu0308rnberg, Erlangen, Germany have published the Article: Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication-Survey among physicians and lay persons in Germany, in the Journal: PLOS ONE
- what: Aim of the study the aim was to survey the minimum threshold of 10-year risk for femoral neck fracture at which physicians would prescribe bisphosphonates and lay persons would be willing to take them (treatment threshold). Still, the study shows similar results . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.